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Education and debate
ICRAM (the International Campaign to Revitalise
Academic Medicine): agenda setting
International Working Party to Promote and Revitalise Academic Medicine
Following the launch by the BMJ and others of the campaign to promote academic medicine, a
working party of 20 medical academics from all over the world was convened to develop a plan of
action
Editorials published in several of the world’s
leading journals in the past few months have heralded
the launch of a global campaign to promote and revi-
talise academic medicine.1 The campaign is a response
to a widely held view that academic medicine is in
crisis.2
In June 2004 the BMJ Publishing Group and others
(www.bmj.com/academicmedicine) convened a work-
ing party of medical academics to discuss the
challenges facing academic medicine. This paper sum-
marises the results of the meeting, and outlines how
the working party will conduct its business in the next
12 months.
What are the roles of academic
medicine?
Academic medicine is traditionally conceived of having
three roles: teaching, research, and service. These roles
are changing: academic medicine still has the primary
responsibility for training doctors; research remains a
core role but more is being done in institutes of
biotechnology and biomedicine; and, most clinical
service, even in academic centres, is now provided by
non-academic doctors.
We strongly feel that it is the “added value” or the
synergy that should exist between these three
roles—when they are brought effectively together—that
defines academic medicine. Traditionally focused on
tertiary hospitals, academic medicine must now extend
more into primary care and public health. The
traditional “clinical service” should be reframed more
broadly as “service to the health system and the
patient.”
How well is academic medicine carrying
out its roles?
We feel that currently academic medicine
x Undervalues our teaching role
x Tolerates the imbalance and lack of communication
between basic research and clinical or applied
research
x Fails to drive innovation and excellence in clinical
practice resulting in indefensible variations in practice
and outcome
x Ignores the essential values of social and global
responsibility.
The growth and imbalance of biomedical research
institutes creates a challenge. How much of this
research will bear a dividend in our health systems, and
when? Who will translate this research into health ben-
efit? Communication between basic and clinical and
health systems researchers seems to have become
increasingly difficult. We seem not to have learned that
the greatest health benefits come from applying what
we already know to more people. We continue to try to
make basic scientists of our best and brightest
clinicians: trainees enrolled in PhD programmes are
typically seeking another new gene instead of working
on clinical safety, quality, and health outcomes. Have
we got the balance right?
Members of the working party are listed on bmj.com
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Another great failing is the lack of focus on the
health needs of populations not normally supported
by academic medicine due to race, ethnic origin, social
class, gender, or geographical location.
What needs to be done to permit
academic medicine to fulfil its roles?
Firstly, we need this campaign, and we need a great
global debate. We need to acknowledge that there is a
crisis and there is a need for change. So, the campaign
is underway and we want your participation.
We need a new vision for academic medicine. We
need a clear definition of the roles of academic
medicine and we need a clear iteration of our values—
what we stand for and what we want to achieve. We
need to clarify the place of academic medicine within
medicine, the health system, and civil society. We need
to articulate and demonstrate the economic and social
value that academic medicine provides. And we need a
global perspective.
We cannot do this alone. We need partner-
ships within academic medicine itself and beyond
medicine, partnerships that cut across traditional
disciplinary and institutional boundaries. We also
need partnerships with others in the health system,
and of course—perhaps more than anything else—we
need partnerships with patients, policy makers, and
the public.
Next steps
During the meeting the working party analysed these
problems and together agreed to work more on several
topics:
x Proposing how academic medicine could listen bet-
ter and improve its relationships with its “customers,”
including patients, policy makers, and practitioners
x Exploring/examining what the values of academic
medicine should be
x Building capacity in academic medicine, including
better career paths
x Developing a vision of how academic medicine
should look in 2020
x Planning how to ensure that the campaign achieves
change.
Five task groups have been formed (box 1). A mem-
ber of the working party convenes each task group, and
the convenors meet by teleconference monthly.
We are developing a series of regional and
stakeholder advisory groups (box 2) to inform and
advise the working party through as broad a range of
consultations as possible. The regional advisory
groups will provide global geographic coverage for
the consultations, and the stakeholder advisory
groups will represent the interests of the various “cus-
tomers” of academic medicine. Out of this we see a
series of working papers being developed to further
stimulate and inform the debate. These working
papers will lead to a series of peer reviewed
publications. The whole working group will meet in
mid-2005 with international policy makers to
complete a final report, which will include recommen-
Box 1: Task groups
Analysing the evidence—This group is collecting and
appraising systematically the available evidence on
academic medicine and its problems3
Careers and training—This group aims to explore the
issues of mentoring and recruitment with a special
emphasis on women and marginalised groups, and to
set up student and trainee international advisory
groups to help explore problems and to propose
possible solutions
Communication and dissemination—This group is
responsible for internal and external communication
strategies and management of publication policies
Stakeholder liaisons and operations—This group is
outlining how the working party will operate and is
establishing collaborative relationships with relevant
regional bodies such as governments, professional
associations and universities
Vision and values—This group is developing a
discussion paper that seeks to explore current values
and then propose a new vision and set of values for
academic medicine
Box 2: Regional and stakeholder advisory
groups
Regional advisory groups are being created for:
• Australasia (East Asia and Pacific)
• Europe
• Latin America and the Caribbean
• Middle East and North Africa
• North America
• South Asia
• Sub-Saharan Africa
Stakeholder advisory groups are being created to
represent the following constituents:
• Academics
• Business and industry
• Government and policy makers
• Journal editors
• Patients
• Professional associations
• Students and trainees
Summary points
Academic medicine worldwide is perceived to be
in crisis
An international working party has been
convened with the aim of revitalising academic
medicine
A series of task groups and regional and
stakeholder advisory groups have been formed to
inform the working party through wide
consultation
Expected outputs include a report with
recommendations and a series of peer reviewed
published papers
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dations for reform in academic medicine and a
platform for action.
We are aware that this effort could easily lead to a
lot of discussion and little action, with a report
produced in 12 months that has minimal impact. Our
challenge is to ensure a different outcome.We hope to
do this through the task groups outlined here and a
range of other consultation processes that we are
currently establishing. We invite all of you to join with
us in changing the face and future of academic
medicine.
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Academic medicine: the evidence base
International Working Party to Promote and Revitalise Academic Medicine
The International Campaign to Revitalise Academic Medicine recognises that an evidence based
approach is important in discussing the problems of academic medicine. A preliminary exploration
of the evidence on academic medicine has led to a research agenda for examining and proposing
realistic solutions
Much has been written about academic medicine and
its ailments. The International Campaign to Revitalise
Academic Medicine (ICRAM) immediately recognised
the importance of an evidence based approach to the
ongoing discussion about academic medicine.1 A task
group was developed to systematically collate and
evaluate the available evidence. We initially targeted
major themes that were readily identifiable as being
important and for which data would be reasonably
straightforward to collect. The type of evidence (box 1)
differed for each research question. Here we present a
summary and future research agenda.
Where are the problems?
The Oxford English Reference Dictionary defines aca-
deme as “the world of learning,” and academic as
“scholarly: to do with learning.” Scholarship is encoun-
tered as a key principle of academic medicine,w1 and it
entails the discovery, integration, and application of
knowledge, and teaching.w2 Academic medicine practi-
tioners are expected to demonstrate systematic and
sustained scholarly effort, with recognisable outputs
valued by peers.
Many doctors teach (for example, over 40% of UK
general practitioners host medical trainees2) or partici-
pate in research sporadically, and the role of such prac-
titioners in the academic enterprise requires more
study. Patients are also increasingly involved in clinical
research,3 education,4 and service5 and are important
academic allies. Finally, scholarship in fields related to
health care and medicine is often pursued by
non-physicians (nurses or laboratory scientists, for
example) who may also encounter the “triple
jeopardy” of trying to excel simultaneously in teaching,
research, and clinical practice.6 However, policies
addressing academic medicine careers typically do not
expand the definition to include these scholars.7
Differing (or even conflicting) professional perspec-
tives may prohibit recognition of common issues and
lead to different groups fighting over available funds.8
Moreover, social and public health responsibilities and
priorities of academic medicine may be different in
affluent societies and in those with poor health
systems.
Situation analyses are useful to identify barriers,
failures, and successful applications in different
settings. Most literature to date has selectively focused
on developed Western countries, a minority in the glo-
bal scale.We conducted an illustrative situation analysis
for China (available from corresponding author).
China has 2.2 million doctors, a third of the world’s
total number. Problems include the need for an
increased academic workforce and structures to
support continuing medical education and the
production of high quality, licensed doctors; dispropor-
tionately low funding for clinical science research; the
Members of the working party, web references, and two tables
of data on most cited authors and trials are on bmj.com
Academic medicine has an uncertain role in the Chinese health system
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